{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T15:21:04Z","timestamp":1790176864102,"version":"4.1.0"},"reference-count":217,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","surveyophthalmol.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Survey of Ophthalmology"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.survophthal.2019.11.001","type":"journal-article","created":{"date-parts":[[2019,11,26]],"date-time":"2019-11-26T19:41:57Z","timestamp":1574797317000},"page":"294-311","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":59,"title":["Mitochondrial disorders and the eye"],"prefix":"10.1016","volume":"65","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8031-1084","authenticated-orcid":false,"given":"Eli","family":"Kisilevsky","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Freund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6738-7225","authenticated-orcid":false,"given":"Edward","family":"Margolin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.survophthal.2019.11.001_bib1","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.15252\/emmm.201606592","article-title":"Modified Atkins diet induces subacute selective ragged-red-fiber lysis in mitochondrial myopathy patients","volume":"8","author":"Ahola","year":"2016","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.survophthal.2019.11.001_bib2","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/1471-2350-13-65","article-title":"Dominant optic atrophy in Denmark - report of 15 novel mutations in OPA1, using a strategy with a detection rate of 90%","volume":"13","author":"Almind","year":"2012","journal-title":"BMC Med Genet"},{"key":"10.1016\/j.survophthal.2019.11.001_bib3","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1016\/j.biocel.2009.04.012","article-title":"OPA1-associated disorders: phenotypes and pathophysiology","volume":"41","author":"Amati-Bonneau","year":"2009","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.survophthal.2019.11.001_bib4","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1093\/brain\/awm298","article-title":"OPA1 mutations induce mitochondrial DNA instability and\u00a0optic atrophy \u2018plus\u2019 phenotypes","volume":"131","author":"Amati-Bonneau","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.survophthal.2019.11.001_bib5","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1111\/j.1442-9071.2010.02335.x","article-title":"Macular lesion resembling adult-onset vitelliform macular dystrophy in Kearns-Sayre syndrome with multiple mtDNA deletions","volume":"38","author":"Ascaso","year":"2010","journal-title":"Clin Exp Ophthalmol"},{"key":"10.1016\/j.survophthal.2019.11.001_bib6","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1093\/brain\/awm067","article-title":"Chronic progressive ophthalmoplegia with large-scale mtDNA rearrangement: can we predict progression?","volume":"130","author":"Aur\u00e9","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.survophthal.2019.11.001_bib7","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1007\/s00417-018-3914-z","article-title":"Mitochondrial A3243G mutation results in corneal endothelial polymegathism","volume":"256","author":"Bakhoum","year":"2018","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.survophthal.2019.11.001_bib8","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1111\/ceo.13326","article-title":"Peripapillary vessel density changes in Leber's hereditary optic neuropathy: a new biomarker","volume":"46","author":"Balducci","year":"2018","journal-title":"Clin Exp Ophthalmol"},{"key":"10.1016\/j.survophthal.2019.11.001_bib9","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1136\/bjophthalmol-2015-307326","article-title":"Macular nerve fibre and ganglion cell layer changes in acute Leber's hereditary optic neuropathy","volume":"100","author":"Balducci","year":"2016","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.survophthal.2019.11.001_bib10","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.ophtha.2009.07.026","article-title":"Natural history of Leber's hereditary optic neuropathy: longitudinal analysis of the retinal nerve fiber layer by optical coherence tomography","volume":"117","author":"Barboni","year":"2010","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2019.11.001_bib11","doi-asserted-by":"crossref","first-page":"5303","DOI":"10.1167\/iovs.06-0520","article-title":"Leber's hereditary optic neuropathy with childhood onset","volume":"47","author":"Barboni","year":"2006","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.survophthal.2019.11.001_bib12","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.ophtha.2004.06.034","article-title":"Retinal nerve fiber layer evaluation by optical coherence tomography in Leber's hereditary optic neuropathy","volume":"112","author":"Barboni","year":"2005","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2019.11.001_bib13","doi-asserted-by":"crossref","first-page":"e231","DOI":"10.1093\/brain\/aws280","article-title":"Idebenone treatment in patients with OPA1-mutant dominant optic atrophy","volume":"136","author":"Barboni","year":"2013","journal-title":"Brain"},{"key":"10.1016\/j.survophthal.2019.11.001_bib14","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/BF00158934","article-title":"ERG and VECP in chronic progressive external ophthalmoplegia (CPEO)","volume":"60","author":"Berdjis","year":"1985","journal-title":"Documenta Ophthalmologica Adv Ophthalmol"},{"key":"10.1016\/j.survophthal.2019.11.001_bib15","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/ana.410010104","article-title":"Lumping or splitting? \u201cophthalmoplegia-plus\u201d or kearns-sayre syndrome?","volume":"1","author":"Berenberg","year":"1977","journal-title":"Ann Neurol"},{"key":"10.1016\/j.survophthal.2019.11.001_bib16","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1159\/000310536","article-title":"Improvement of Kearns-Sayre syndrome with controlled carbohydrate intake and coenzyme Q10 therapy","volume":"208","author":"Berio","year":"1994","journal-title":"Ophthalmologica"},{"key":"10.1016\/j.survophthal.2019.11.001_bib17","first-page":"169","article-title":"Kearns-Sayre syndrome with facial and white matter extensive involvement: a (mitochondrial and nuclear gene related?) neurocristopathy?","volume":"39","author":"Berio","year":"2017","journal-title":"Pediatr Med Chir"},{"key":"10.1016\/j.survophthal.2019.11.001_bib18","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1212\/01.WNL.0000033795.17156.00","article-title":"Diagnostic criteria for respiratory chain disorders in adults and children","volume":"59","author":"Bernier","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.survophthal.2019.11.001_bib19","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/sj.ejhg.5201363","article-title":"LHON\/MELAS overlap syndrome associated with a mitochondrial MTND1 gene mutation","volume":"13","author":"Blakely","year":"2005","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.survophthal.2019.11.001_bib20","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.ajo.2018.05.029","article-title":"Topographic macular microvascular changes and correlation with visual loss in chronic leber hereditary optic neuropathy","volume":"192","author":"Borrelli","year":"2018","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.survophthal.2019.11.001_bib21","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1093\/brain\/awg101","article-title":"Executive and visuospatial deficits in patients with chronic progressive external ophthalmoplegia and Kearns-Sayre Syndrome","volume":"126","author":"Bosbach","year":"2003","journal-title":"Brain"},{"key":"10.1016\/j.survophthal.2019.11.001_bib22","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/ng1776","article-title":"Systematic identification of human mitochondrial disease genes through integrative genomics","volume":"38","author":"Calvo","year":"2006","journal-title":"Nat Genet"},{"key":"10.1016\/j.survophthal.2019.11.001_bib23","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1097\/WNO.0000000000000570","article-title":"International consensus statement on the clinical and therapeutic management of leber hereditary optic neuropathy","volume":"37","author":"Carelli","year":"2017","journal-title":"J\u00a0Neuroophthalmol"},{"key":"10.1016\/j.survophthal.2019.11.001_bib24","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1093\/brain\/102.3.559","article-title":"Leber's optic neuropathy: a clinical and visual evoked potential study of affected and asymptomatic members of a six generation family","volume":"102","author":"Carroll","year":"1979","journal-title":"Brain"},{"key":"10.1016\/j.survophthal.2019.11.001_bib25","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/ar.1092140103","article-title":"Mitochondrial morphometrics of histochemically identified human extraocular muscle fibers","volume":"214","author":"Carry","year":"1986","journal-title":"Anatomical Rec"},{"key":"10.1016\/j.survophthal.2019.11.001_bib26","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1136\/bjo.2004.060590","article-title":"Human extraocular muscles in mitochondrial diseases: comparing chronic progressive external ophthalmoplegia with Leber's hereditary optic neuropathy","volume":"89","author":"Carta","year":"2005","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.survophthal.2019.11.001_bib27","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/1096-8628(20010122)98:3<235::AID-AJMG1086>3.0.CO;2-O","article-title":"Leber hereditary optic neuropathy: does heteroplasmy influence the inheritance and expression of the G11778A mitochondrial DNA mutation?","volume":"98","author":"Chinnery","year":"2001","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.survophthal.2019.11.001_bib28","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/S0140-6736(04)16851-7","article-title":"Risk of developing a mitochondrial DNA deletion disorder","volume":"364","author":"Chinnery","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.survophthal.2019.11.001_bib29","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1002\/1531-8249(200008)48:2<188::AID-ANA8>3.0.CO;2-P","article-title":"The epidemiology of pathogenic mitochondrial DNA mutations","volume":"48","author":"Chinnery","year":"2000","journal-title":"Ann Neurol"},{"key":"10.1016\/j.survophthal.2019.11.001_bib30","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/nrendo.2016.151","article-title":"Mitochondrial disease and endocrine dysfunction","volume":"13","author":"Chow","year":"2017","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.survophthal.2019.11.001_bib31","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1097\/ICU.0000000000000314","article-title":"Dominant optic atrophy: updates on the pathophysiology and clinical manifestations of the optic atrophy 1 mutation","volume":"27","author":"Chun","year":"2016","journal-title":"Curr Opin Ophthalmol"},{"key":"10.1016\/j.survophthal.2019.11.001_bib32","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1136\/bjo.2007.134726","article-title":"The natural history of OPA1-related autosomal dominant optic atrophy","volume":"92","author":"Cohn","year":"2008","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.survophthal.2019.11.001_bib33","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.ajo.2006.12.038","article-title":"Autosomal dominant optic atrophy: penetrance and expressivity in patients with OPA1 mutations","volume":"143","author":"Cohn","year":"2007","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.survophthal.2019.11.001_bib34","article-title":"Optic Atrophy Type 1","volume":"2018","author":"Delettre-Cribaillet","year":"2015"},{"key":"10.1016\/j.survophthal.2019.11.001_bib35","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.1056\/NEJMra022567","article-title":"Mitochondrial respiratory-chain diseases","volume":"348","author":"DiMauro","year":"2003","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.survophthal.2019.11.001_bib36","first-page":"12","article-title":"Eyelid surgery in ocular myopathies","volume":"32","author":"Doherty","year":"2013","journal-title":"Orbit (Amsterdam, Netherlands)"},{"key":"10.1016\/j.survophthal.2019.11.001_bib37","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1002\/path.2018","article-title":"Statin therapy induces ultrastructural damage in skeletal muscle in patients without myalgia","volume":"210","author":"Draeger","year":"2006","journal-title":"J\u00a0Pathol"},{"key":"10.1016\/j.survophthal.2019.11.001_bib38","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1016\/S0161-6420(82)34619-9","article-title":"The atypical pigmentary retinopathy of Kearns-Sayre syndrome","volume":"89","author":"Eagle","year":"2013","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2019.11.001_bib39","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1016\/S0161-6420(82)34619-9","article-title":"The atypical pigmentary retinopathy of Kearns-Sayre syndrome. A light and electron microscopic study","volume":"89","author":"Eagle","year":"1982","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2019.11.001_bib40","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1093\/hmg\/3.6.977","article-title":"Dominant optic atrophy (OPA1) mapped to chromosome 3q region. I. Linkage analysis","volume":"3","author":"Eiberg","year":"1994","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.survophthal.2019.11.001_bib41","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.ymgme.2015.06.004","article-title":"MELAS syndrome: clinical manifestations, pathogenesis, and treatment options","volume":"116","author":"El-Hattab","year":"2015","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.survophthal.2019.11.001_bib42","series-title":"GeneReviews\u00ae","article-title":"MELAS","author":"El-Hattab","year":"2001"},{"key":"10.1016\/j.survophthal.2019.11.001_bib43","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.ymgme.2012.06.018","article-title":"Citrulline and arginine utility in treating nitric oxide deficiency in mitochondrial disorders","volume":"107","author":"El-Hattab","year":"2012","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.survophthal.2019.11.001_bib44","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.ymgme.2016.01.010","article-title":"Impaired nitric oxide production in children with MELAS syndrome and the effect of arginine and citrulline supplementation","volume":"117","author":"El-Hattab","year":"2016","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.survophthal.2019.11.001_bib45","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1101\/gr.108696.110","article-title":"OPA1 links human mitochondrial genome maintenance to mtDNA replication and distribution","volume":"21","author":"Elachouri","year":"2011","journal-title":"Genome Res"},{"key":"10.1016\/j.survophthal.2019.11.001_bib46","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.ajhg.2008.07.004","article-title":"Pathogenic mitochondrial DNA mutations are common in the general population","volume":"83","author":"Elliott","year":"2008","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.survophthal.2019.11.001_bib47","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.ajhg.2008.08.013","article-title":"Optimized allotopic expression of the human mitochondrial ND4 prevents blindness in a rat model of mitochondrial dysfunction","volume":"83","author":"Ellouze","year":"2008","journal-title":"Am J Hum Genet"},{"issue":"1","key":"10.1016\/j.survophthal.2019.11.001_bib48","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1186\/s13023-019-1187-1","article-title":"OPA1: 516 unique variants and 831 patients registered in an updated centralized Variome database","volume":"14","author":"Le Roux","year":"2019","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.survophthal.2019.11.001_bib49","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.ophtha.2015.10.025","article-title":"Gene therapy for leber hereditary optic neuropathy: initial results","volume":"123","author":"Feuer","year":"2016","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2019.11.001_bib50","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jcjd.2016.03.005","article-title":"Diabetes in Kearns-Sayre syndrome: more common than anticipated","volume":"40","author":"Finsterer","year":"2016","journal-title":"Can J Diabetes"},{"key":"10.1016\/j.survophthal.2019.11.001_bib51","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1080\/13816810.2018.1488172","article-title":"Retinal involvement in m.3243A>G carriers","volume":"39","author":"Finsterer","year":"2018","journal-title":"Ophthalmic Genet"},{"key":"10.1016\/j.survophthal.2019.11.001_bib52","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1177\/0883073815599263","article-title":"The eye on mitochondrial disorders","volume":"31","author":"Finsterer","year":"2016","journal-title":"J\u00a0Child Neurol"},{"key":"10.1016\/j.survophthal.2019.11.001_bib53","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1093\/brain\/awn269","article-title":"Visual system involvement in patients with Friedreich's ataxia","volume":"132","author":"Fortuna","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.survophthal.2019.11.001_bib54","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1016\/j.ophtha.2008.08.006","article-title":"Diplopia, blepharoptosis, and ophthalmoplegia and 3-hydroxy-3-methyl-glutaryl-CoA reductase inhibitor use","volume":"115","author":"Fraunfelder","year":"2008","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2019.11.001_bib55","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ceca.2014.11.008","article-title":"Mitochondrial Ca2+ uptake correlates with the severity of the symptoms in autosomal dominant optic atrophy","volume":"57","author":"F\u00fcl\u00f6p","year":"2015","journal-title":"Cell Calcium"},{"key":"10.1016\/j.survophthal.2019.11.001_bib56","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1093\/brain\/awq276","article-title":"Oestrogens ameliorate mitochondrial dysfunction in Leber's hereditary optic neuropathy","volume":"134","author":"Giordano","year":"2011","journal-title":"Brain"},{"key":"10.1016\/j.survophthal.2019.11.001_bib57","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.bbabio.2018.04.006","article-title":"The idebenone metabolite QS10 restores electron transfer in complex I and coenzyme Q defects","volume":"1859","author":"Giorgio","year":"2018","journal-title":"Biochim Biophys Acta Bioenerg"},{"key":"10.1016\/j.survophthal.2019.11.001_bib58","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1002\/ana.24362","article-title":"Prevalence of nuclear and mitochondrial DNA mutations related to adult mitochondrial disease","volume":"77","author":"Gorman","year":"2015","journal-title":"Ann Neurol"},{"key":"10.1016\/j.survophthal.2019.11.001_bib59","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/348651a0","article-title":"A\u00a0mutation in the tRNA(Leu)(UUR) gene associated with the MELAS subgroup of mitochondrial encephalomyopathies","volume":"348","author":"Goto","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.survophthal.2019.11.001_bib60","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.201708262","article-title":"mtDNA heteroplasmy level and copy number indicate disease burden in m.3243A>G mitochondrial disease","volume":"10","author":"Grady","year":"2018","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.survophthal.2019.11.001_bib61","doi-asserted-by":"crossref","first-page":"3340","DOI":"10.1167\/iovs.09-4659","article-title":"Mitochondrial DNA defects and selective extraocular muscle involvement in CPEO","volume":"51","author":"Greaves","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.survophthal.2019.11.001_bib62","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1016\/j.ophtha.2017.05.016","article-title":"Gene therapy for leber hereditary optic neuropathy: low- and medium-dose visual results","volume":"124","author":"Guy","year":"2017","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2019.11.001_bib63","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1167\/iovs.13-13365","article-title":"Retinal ganglion cell dysfunction in asymptomatic G11778A: leber hereditary optic neuropathy","volume":"55","author":"Guy","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.survophthal.2019.11.001_bib64","first-page":"361","article-title":"Endocrine disorders in primary mitochondrial disease","volume":"2","author":"Haas","year":"2018","journal-title":"J\u00a0Endocr Soc"},{"key":"10.1016\/j.survophthal.2019.11.001_bib65","doi-asserted-by":"crossref","first-page":"e17963","DOI":"10.1371\/journal.pone.0017963","article-title":"NQO1-dependent redox cycling of idebenone: effects on cellular redox potential and energy levels","volume":"6","author":"Haefeli","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.survophthal.2019.11.001_bib66","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1136\/jnnp-2013-306748","article-title":"SANDO syndrome in a cohort of 107 patients with CPEO and mitochondrial DNA deletions","volume":"86","author":"Hanisch","year":"2015","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"issue":"Pt 4","key":"10.1016\/j.survophthal.2019.11.001_bib67","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1093\/brain\/115.4.979","article-title":"Occurrence of a multiple sclerosis-like illness in women who have a Leber's hereditary optic neuropathy mitochondrial DNA mutation","volume":"115","author":"Harding","year":"1992","journal-title":"Brain"},{"key":"10.1016\/j.survophthal.2019.11.001_bib68","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/j.1365-2265.1992.tb02289.x","article-title":"Endocrine dysfunction in Kearns-Sayre syndrome","volume":"37","author":"Harvey","year":"1992","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.survophthal.2019.11.001_bib69","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1002\/ana.410290606","article-title":"Strongly succinate dehydrogenase-reactive blood vessels in muscles from patients with mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes","volume":"29","author":"Hasegawa","year":"1991","journal-title":"Ann Neurol"},{"key":"10.1016\/j.survophthal.2019.11.001_bib70","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.mito.2016.11.007","article-title":"Dysphagia is prevalent in patients with CPEO and single, large-scale deletions in mtDNA","volume":"32","author":"Hedermann","year":"2017","journal-title":"Mitochondrion"},{"key":"10.1016\/j.survophthal.2019.11.001_bib71","doi-asserted-by":"crossref","first-page":"107","DOI":"10.3109\/01658107.2016.1173709","article-title":"The optical coherence tomographic profile of leber hereditary optic neuropathy","volume":"40","author":"Hedges","year":"2016","journal-title":"Neuroophthalmology"},{"key":"10.1016\/j.survophthal.2019.11.001_bib72","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1167\/iovs.09-3606","article-title":"Electrophysiological and histologic assessment of retinal ganglion cell fate in a mouse model for OPA1-associated autosomal dominant optic atrophy","volume":"51","author":"Heiduschka","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.survophthal.2019.11.001_bib73","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.mito.2017.12.006","article-title":"Clinical and demographic features of chronic progressive external ophthalmoplegia in a large adult-onset cohort","volume":"44","author":"Heighton","year":"2018","journal-title":"Mitochondrion"},{"key":"10.1016\/j.survophthal.2019.11.001_bib74","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0960-8966(92)90045-8","article-title":"Melas: an original case and clinical criteria for diagnosis","volume":"2","author":"Hirano","year":"1992","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.survophthal.2019.11.001_bib75","doi-asserted-by":"crossref","first-page":"23287","DOI":"10.1074\/jbc.M201154200","article-title":"The C66W mutation in the deafness dystonia peptide 1 (DDP1) affects the formation of functional DDP1.TIM13 complexes in the mitochondrial intermembrane space","volume":"277","author":"Hofmann","year":"2002","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.survophthal.2019.11.001_bib76","first-page":"935","article-title":"Leber hereditary optic neuropathy: involvement of the mitochondrial ND1 gene and evidence for an intragenic suppressor mutation","volume":"48","author":"Howell","year":"1991","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.survophthal.2019.11.001_bib77","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1093\/brain\/awm272","article-title":"Mutation of OPA1 causes dominant optic atrophy with external ophthalmoplegia, ataxia, deafness and multiple mitochondrial DNA deletions: a novel disorder of mtDNA maintenance","volume":"131","author":"Hudson","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.survophthal.2019.11.001_bib78","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1212\/01.WNL.0000091888.26232.FE","article-title":"Slowly progressive spread of the stroke-like lesions in MELAS","volume":"61","author":"Iizuka","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.survophthal.2019.11.001_bib79","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1007\/s10384-005-0308-7","article-title":"Leber's hereditary optic neuropathy precipitated by ethambutol","volume":"50","author":"Ikeda","year":"2006","journal-title":"Jpn J Ophthalmol"},{"key":"10.1016\/j.survophthal.2019.11.001_bib80","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ijcard.2018.12.064","article-title":"The necessity of implantable cardioverter defibrillators in patients with Kearns-Sayre syndrome - systematic review of the articles","volume":"279","author":"Imamura","year":"2019","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.survophthal.2019.11.001_bib81","doi-asserted-by":"crossref","first-page":"e580","DOI":"10.1111\/aos.12999","article-title":"The reduction of temporal optic nerve head microcirculation in autosomal dominant optic atrophy","volume":"94","author":"Inoue","year":"2016","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.survophthal.2019.11.001_bib82","doi-asserted-by":"crossref","first-page":"4079","DOI":"10.1167\/iovs.07-0024","article-title":"Reduction of inner retinal thickness in patients with autosomal dominant optic atrophy associated with OPA1 mutations","volume":"48","author":"Ito","year":"2007","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.survophthal.2019.11.001_bib83","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s10633-015-9489-7","article-title":"Clinical and electrophysiology findings in Slovene patients with Leber hereditary optic neuropathy","volume":"130","author":"Jarc-Vidmar","year":"2015","journal-title":"Doc Ophthalmol"},{"key":"10.1016\/j.survophthal.2019.11.001_bib84","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1159\/000316480","article-title":"The importance of mitochondria in age-related and inherited eye disorders","volume":"44","author":"Jarrett","year":"2010","journal-title":"Ophthalmic Res"},{"key":"10.1016\/j.survophthal.2019.11.001_bib85","first-page":"416","article-title":"Evaluation of the X-linked modifier loci for Leber hereditary optic neuropathy with the G11778A mutation in Chinese","volume":"16","author":"Ji","year":"2010","journal-title":"Mol Vis"},{"key":"10.1016\/j.survophthal.2019.11.001_bib86","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1001\/archopht.1993.01090040087038","article-title":"Leber's hereditary optic neuropathy. Clinical manifestations of the 14484 mutation","volume":"111","author":"Johns","year":"1993","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.survophthal.2019.11.001_bib87","first-page":"e83","article-title":"Surgical technique for pulled in two syndrome: three cases with chronic progressive external ophthalmoplegia","volume":"54","author":"Jones","year":"2017","journal-title":"J\u00a0Pediatr Ophthalmol Strabismus"},{"key":"10.1016\/j.survophthal.2019.11.001_bib88","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.ijcard.2014.12.038","article-title":"Systematic review of cardiac electrical disease in Kearns-Sayre syndrome and mitochondrial cytopathy","volume":"181","author":"Kabunga","year":"2015","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.survophthal.2019.11.001_bib89","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2014-206499","article-title":"Macular pattern dystrophy and homonymous hemianopia in MELAS syndrome","volume":"2015","author":"Kamal-Salah","year":"2015","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.survophthal.2019.11.001_bib90","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/and.12711","article-title":"A\u00a0case of hypopituitarism accompanying Kearns\u2013Sayre syndrome treated with human chorionic gonadotropin: a case report and literature review","volume":"49","author":"Kang","year":"2017","journal-title":"Andrologia"},{"key":"10.1016\/j.survophthal.2019.11.001_bib91","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/pedi.12223","article-title":"The spectrum of clinical presentation, diagnosis, and management of mitochondrial forms of diabetes","volume":"16","author":"Karaa","year":"2015","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/j.survophthal.2019.11.001_bib92","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1080\/01676830.2017.1383475","article-title":"Scleral contact lenses for the management of complicated ptosis","volume":"37","author":"Katsoulos","year":"2018","journal-title":"Orbit (London)"},{"key":"10.1016\/j.survophthal.2019.11.001_bib93","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1212\/WNL.0b013e31823a0c7f","article-title":"Natural history of MELAS associated with mitochondrial DNA m.3243A>G genotype","volume":"77","author":"Kaufmann","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.survophthal.2019.11.001_bib94","first-page":"559","article-title":"External ophthalmoplegia, pigmentary degeneration of the retina, and cardiomyopathy: a newly recognized syndrome","volume":"63","author":"Kearns","year":"1965","journal-title":"Trans Am Ophthalmological Soc"},{"key":"10.1016\/j.survophthal.2019.11.001_bib95","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1001\/archopht.1958.00940080296016","article-title":"Retinitis pigmentosa, external ophthalmophegia, and complete heart block: unusual syndrome with histologic study in one of two cases","volume":"60","author":"Kearns","year":"1958","journal-title":"A.M.A Archives Ophthalmology"},{"key":"10.1016\/j.survophthal.2019.11.001_bib96","first-page":"325","article-title":"Kearns-Sayre syndrome: a case series of 35 adults and children","volume":"7","author":"Khambatta","year":"2014","journal-title":"Int J Gen Med"},{"key":"10.1016\/j.survophthal.2019.11.001_bib97","first-page":"480","article-title":"Defects in mitochondrial protein synthesis and respiratory chain activity segregate with the tRNA(Leu(UUR)) mutation associated with mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes","volume":"12","author":"King","year":"1992","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.survophthal.2019.11.001_bib98","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1136\/jmg.2004.020537","article-title":"Mutations of the mitochondrial ND1 gene as a cause of MELAS","volume":"41","author":"Kirby","year":"2004","journal-title":"J\u00a0Med Genet"},{"key":"10.1016\/j.survophthal.2019.11.001_bib99","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1600-0420.1996.tb00672.x","article-title":"Dominant optic atrophy mapped to chromosome 3q region. II. Clinical and epidemiological aspects","volume":"74","author":"Kjer","year":"1996","journal-title":"Acta Ophthalmol Scand"},{"key":"10.1016\/j.survophthal.2019.11.001_bib100","doi-asserted-by":"crossref","first-page":"2980","DOI":"10.1093\/brain\/aws240","article-title":"Spastic paraplegia gene 7 in patients with spasticity and\/or optic neuropathy","volume":"135","author":"Klebe","year":"2012","journal-title":"Brain"},{"key":"10.1016\/j.survophthal.2019.11.001_bib101","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1001\/jamaneurol.2015.5072","article-title":"Recommendations for the management of strokelike episodes in patients with mitochondrial encephalomyopathy, lactic acidosis, and strokelike episodes","volume":"73","author":"Koenig","year":"2016","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.survophthal.2019.11.001_bib102","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1212\/01.WNL.0000151976.60624.01","article-title":"L-arginine improves the symptoms of strokelike episodes in MELAS","volume":"64","author":"Koga","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.survophthal.2019.11.001_bib103","first-page":"2861","article-title":"Therapeutic regimen of L-arginine for MELAS: 9-year, prospective, multicenter, clinical research","volume":"265","author":"Koga","year":"2018","journal-title":"J\u00a0Neurol"},{"key":"10.1016\/j.survophthal.2019.11.001_bib104","first-page":"1101","article-title":"Sensorineural hearing loss in patients with chronic progressive external ophthalmoplegia or Kearns-Sayre syndrome","volume":"252","author":"Kornblum","year":"2005","journal-title":"J\u00a0Neurol"},{"key":"10.1016\/j.survophthal.2019.11.001_bib105","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1097\/ICB.0000000000000503","article-title":"New observations regarding the retinopathy of genetically confirmed Kearns-Sayre Syndrome","volume":"12","author":"Kozak","year":"2018","journal-title":"Retin cases brief Rep"},{"key":"10.1016\/j.survophthal.2019.11.001_bib106","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s10633-004-8676-8","article-title":"Inner retinal contributions to the multifocal electroretinogram: patients with Leber's hereditary optic neuropathy (LHON). Multifocal ERG in patients with LHON","volume":"108","author":"Kurtenbach","year":"2004","journal-title":"Doc Ophthalmol"},{"key":"10.1016\/j.survophthal.2019.11.001_bib107","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/S0002-9394(99)00057-4","article-title":"Mitochondrial maculopathy: geographic atrophy of the macula in the MELAS associated A to G 3243 mitochondrial DNA point mutation","volume":"128","author":"Latkany","year":"1999","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.survophthal.2019.11.001_bib108","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1136\/bjo.64.10.751","article-title":"Leber's optic neuropathy: clinical and visual evoked response studies in asymptomatic and symptomatic members of a 4-generation family","volume":"64","author":"Livingstone","year":"1980","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.survophthal.2019.11.001_bib109","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1002\/ana.20278","article-title":"Deficit of in\u00a0vivo mitochondrial ATP production in OPA1-related dominant optic atrophy","volume":"56","author":"Lodi","year":"2004","journal-title":"Ann Neurol"},{"key":"10.1016\/j.survophthal.2019.11.001_bib110","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.mito.2009.04.005","article-title":"CPEO and KSS differ in the percentage and location of the mtDNA deletion","volume":"9","author":"L\u00f3pez-Gallardo","year":"2009","journal-title":"Mitochondrion"},{"key":"10.1016\/j.survophthal.2019.11.001_bib111","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/S0002-9394(14)72429-8","article-title":"Variable genotype of Leber's hereditary optic neuropathy patients","volume":"109","author":"Lott","year":"1990","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.survophthal.2019.11.001_bib112","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/sj.eye.6700362","article-title":"Leber's hereditary optic neuropathy triggered by antiretroviral therapy for human immunodeficiency virus","volume":"17","author":"Mackey","year":"2003","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.survophthal.2019.11.001_bib113","first-page":"481","article-title":"Primary pathogenic mtDNA mutations in multigeneration pedigrees with Leber hereditary optic neuropathy","volume":"59","author":"Mackey","year":"1996","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.survophthal.2019.11.001_bib114","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1086\/301959","article-title":"Epidemiology of A3243G, the mutation for mitochondrial encephalomyopathy, lactic acidosis, and strokelike episodes: prevalence of the mutation in an adult population","volume":"63","author":"Majamaa","year":"1998","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.survophthal.2019.11.001_bib115","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.mito.2006.12.004","article-title":"Population prevalence of the MELAS A3243G mutation","volume":"7","author":"Manwaring","year":"2007","journal-title":"Mitochondrion"},{"key":"10.1016\/j.survophthal.2019.11.001_bib116","first-page":"818","article-title":"Optic neuropathy after treatment with anti-tuberculous drugs in a subject with Leber's hereditary optic neuropathy mutation","volume":"248","author":"De Marinis","year":"2001","journal-title":"J\u00a0Neurol"},{"key":"10.1016\/j.survophthal.2019.11.001_bib117","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1242\/dmm.008706","article-title":"Understanding the genetic and molecular pathogenesis of Friedreich's ataxia through animal and cellular models","volume":"5","author":"Martelli","year":"2012","journal-title":"Dis Model Mech"},{"key":"10.1016\/j.survophthal.2019.11.001_bib118","doi-asserted-by":"crossref","first-page":"461","DOI":"10.5301\/ejo.5000055","article-title":"Meta-analysis of the prevalence of Leber hereditary optic neuropathy mtDNA mutations in Europe","volume":"22","author":"Mascialino","year":"2012","journal-title":"Eur J Ophthalmol"},{"key":"10.1016\/j.survophthal.2019.11.001_bib119","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/0140-6736(92)91442-B","article-title":"Remission of Leber's hereditary optic neuropathy with idebenone","volume":"340","author":"Mashima","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/j.survophthal.2019.11.001_bib120","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/j.1399-0004.1996.tb02732.x","article-title":"High incidence of pre-excitation syndrome in Japanese families with Leber's hereditary optic neuropathy","volume":"50","author":"Mashima","year":"1996","journal-title":"Clin Genet"},{"key":"10.1016\/j.survophthal.2019.11.001_bib121","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s11910-016-0652-7","article-title":"Progressive external ophthalmoplegia","volume":"16","author":"McClelland","year":"2016","journal-title":"Curr Neurol Neurosci Rep"},{"key":"10.1016\/j.survophthal.2019.11.001_bib122","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1093\/jnen\/nlw118","article-title":"Pathological confirmation of optic neuropathy in familial dysautonomia","volume":"76","author":"Mendoza-Santiesteban","year":"2017","journal-title":"J\u00a0Neuropathol Exp Neurol"},{"key":"10.1016\/j.survophthal.2019.11.001_bib123","series-title":"Mitochondria The dynamic Organelle","year":"2007"},{"key":"10.1016\/j.survophthal.2019.11.001_bib124","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0960-8966(93)90040-Q","article-title":"Atypical clinical presentations associated with the MELAS mutation at position 3243 of human mitochondrial DNA","volume":"3","author":"Moraes","year":"1993","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.survophthal.2019.11.001_bib125","doi-asserted-by":"crossref","first-page":"3872","DOI":"10.1167\/iovs.15-17328","article-title":"Retinal ganglion cell and inner plexiform layer loss correlate with visual acuity loss in LHON: a longitudinal, segmentation OCT analysis","volume":"57","author":"Moster","year":"2016","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.survophthal.2019.11.001_bib126","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/0921-8734(92)90016-I","article-title":"Progressive loss of cytochrome c oxidase in the human extraocular muscles in ageing - a cytochemical-immunohistochemical study","volume":"275","author":"M\u00fcller-H\u00f6cker","year":"1992","journal-title":"Mutat Res DNAging"},{"key":"10.1016\/j.survophthal.2019.11.001_bib127","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1001\/archopht.1985.01050120059020","article-title":"The retinal manifestations of mitochondrial myopathy","volume":"103","author":"Mullie","year":"2011","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.survophthal.2019.11.001_bib128","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1136\/jnnp-2012-303528","article-title":"The UK MRC Mitochondrial Disease Patient Cohort Study: Clinical phenotypes associated with the m.3243A>G mutation - Implications for diagnosis and management","volume":"84","author":"Nesbitt","year":"2013","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.survophthal.2019.11.001_bib129","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.ajo.2005.03.058","article-title":"Prophylaxis for second eye involvement in leber hereditary optic neuropathy: an open-labeled, nonrandomized multicenter trial of topical brimonidine purite","volume":"140","author":"Newman","year":"2005","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.survophthal.2019.11.001_bib130","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1001\/archopht.1983.01040020061011","article-title":"Ophthalmoscopic findings in Leber's hereditary optic neuropathy. II. The fundus findings in the affected family members","volume":"101","author":"Nikoskelainen","year":"1983","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.survophthal.2019.11.001_bib131","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1001\/archopht.1984.01040030783017","article-title":"Fundus findings in Leber's hereditary optic neuroretinopathy. III. Fluorescein angiographic studies","volume":"102","author":"Nikoskelainen","year":"1984","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.survophthal.2019.11.001_bib132","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/S0140-6736(94)92830-4","article-title":"Pre-excitation syndrome in Leber's hereditary optic neuropathy","volume":"344","author":"Nikoskelainen","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.survophthal.2019.11.001_bib133","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0960-8966(00)00159-0","article-title":"MNGIE from nuclear DNA to mitochondrial DNA","volume":"11","author":"Nishino","year":"2001","journal-title":"Neuromuscular Disord"},{"key":"10.1016\/j.survophthal.2019.11.001_bib134","first-page":"5985702","article-title":"Analysis of visual field defects obtained with semiautomated kinetic perimetry in patients with leber hereditary optic neuropathy","volume":"2018","author":"Nowomiejska","year":"2018","journal-title":"J\u00a0Ophthalmol"},{"key":"10.1016\/j.survophthal.2019.11.001_bib135","doi-asserted-by":"crossref","first-page":"7743","DOI":"10.1074\/jbc.C200677200","article-title":"Loss of OPA1 perturbates the mitochondrial inner membrane structure and integrity, leading to cytochrome c release and apoptosis","volume":"278","author":"Olichon","year":"2003","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.survophthal.2019.11.001_bib136","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/j.1600-0404.1995.tb07016.x","article-title":"Leber's hereditary optic neuropathy associated with a disorder indistinguishable from multiple sclerosis in a male harbouring the mitochondrial DNA 11778 mutation","volume":"91","author":"Olsen","year":"1995","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.survophthal.2019.11.001_bib137","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1136\/jmg.31.4.280","article-title":"Leber's hereditary optic neuropathy: correlations between mitochondrial genotype and visual outcome","volume":"31","author":"Oostra","year":"1994","journal-title":"J\u00a0Med Genet"},{"key":"10.1016\/j.survophthal.2019.11.001_bib138","doi-asserted-by":"crossref","first-page":"7608","DOI":"10.1167\/iovs.12-10452","article-title":"Mathematically modeling the involvement of axons in Leber's hereditary optic neuropathy","volume":"53","author":"Pan","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.survophthal.2019.11.001_bib139","doi-asserted-by":"crossref","DOI":"10.1038\/gim.2017.107","article-title":"Patient care standards for primary mitochondrial disease: a consensus statement from the Mitochondrial Medicine Society","volume":"19","author":"Parikh","year":"2017","journal-title":"Genet Med"},{"key":"10.1016\/j.survophthal.2019.11.001_bib140","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/ana.410160409","article-title":"Mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes: a distinctive clinical syndrome","volume":"16","author":"Pavlakis","year":"1984","journal-title":"Ann Neurol"},{"key":"10.1016\/j.survophthal.2019.11.001_bib141","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1093\/hmg\/10.13.1359","article-title":"OPA1 mutations in patients with autosomal dominant optic atrophy and evidence for semi-dominant inheritance","volume":"10","author":"Pesch","year":"2001","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.survophthal.2019.11.001_bib142","doi-asserted-by":"crossref","DOI":"10.1093\/brain\/109.5.915","article-title":"The clinical features of mitochondrial myopathy","author":"Petty","year":"1986","journal-title":"Brain"},{"key":"10.1016\/j.survophthal.2019.11.001_bib143","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1017\/S031716710001115X","article-title":"Multisystem disorder in late-onset chronic progressive external ophthalmoplegia","volume":"38","author":"Pfeffer","year":"2011","journal-title":"Can J Neurol Sci"},{"key":"10.1016\/j.survophthal.2019.11.001_bib144","first-page":"529","article-title":"External ophthalmoplegia in human immunodeficiency virus-infected patients receiving antiretroviral therapy","volume":"16","author":"Pineles","year":"2012","journal-title":"J\u00a0AAPOS"},{"key":"10.1016\/j.survophthal.2019.11.001_bib145","first-page":"6921","article-title":"Targeting estrogen receptor \u03b2 as preventive therapeutic strategy for Leber's hereditary optic neuropathy","volume":"24","author":"Pisano","year":"2015","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.survophthal.2019.11.001_bib146","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1007\/s00330-015-3801-5","article-title":"Extra-ocular muscle MRI in genetically-defined mitochondrial disease","volume":"26","author":"Pitceathly","year":"2016","journal-title":"Eur Radiol"},{"key":"10.1016\/j.survophthal.2019.11.001_bib147","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.nmd.2012.03.009","article-title":"Single deletions in mitochondrial DNA - molecular mechanisms and disease phenotypes in clinical practice","volume":"22","author":"Pitceathly","year":"2012","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.survophthal.2019.11.001_bib148","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1186\/s13023-014-0217-2","article-title":"Follow-up of folinic acid supplementation for patients with cerebral folate deficiency and Kearns-Sayre syndrome","volume":"9","author":"Quijada-Fraile","year":"2014","journal-title":"Orphanet J rare Dis"},{"key":"10.1016\/j.survophthal.2019.11.001_bib149","first-page":"1319","article-title":"Efficacy of growth hormone therapy in Kearns-Sayre syndrome: the KIGS experience","volume":"29","author":"Quintos","year":"2016","journal-title":"J\u00a0Pediatr Endocrinol Metab"},{"key":"10.1016\/j.survophthal.2019.11.001_bib150","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1136\/bjo.2005.074526","article-title":"Colour vision defects in asymptomatic carriers of the Leber's hereditary optic neuropathy (LHON) mtDNA 11778 mutation from a large Brazilian LHON pedigree: a case-control study","volume":"90","author":"Quiros","year":"2006","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.survophthal.2019.11.001_bib151","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.cell.2015.03.051","article-title":"Selective elimination of mitochondrial mutations in the germline by genome editing","volume":"161","author":"Reddy","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.survophthal.2019.11.001_bib152","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1212\/01.WNL.0000154518.31302.ED","article-title":"Prevalence of large-scale mitochondrial DNA deletions in an adult Finnish population","volume":"64","author":"Remes","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.survophthal.2019.11.001_bib153","doi-asserted-by":"crossref","first-page":"e110","DOI":"10.1136\/jmg.2003.016576","article-title":"OPA3 gene mutations responsible for autosomal dominant optic atrophy and cataract","volume":"41","author":"Reynier","year":"2004","journal-title":"J\u00a0Med Genet"},{"key":"10.1016\/j.survophthal.2019.11.001_bib154","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1038\/sj.eye.6701488","article-title":"Ocular motility findings in chronic progressive external ophthalmoplegia","volume":"19","author":"Richardson","year":"2005","journal-title":"Eye"},{"key":"10.1016\/j.survophthal.2019.11.001_bib155","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1167\/iovs.15-18306","article-title":"Prevalence and genetics of leber hereditary optic neuropathy in the Danish population","volume":"57","author":"Rosenberg","year":"2016","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.survophthal.2019.11.001_bib156","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1093\/brain\/awr323","article-title":"The MFN2 gene is responsible for mitochondrial DNA instability and optic atrophy 'plus' phenotype","volume":"135","author":"Rouzier","year":"2012","journal-title":"Brain"},{"key":"10.1016\/j.survophthal.2019.11.001_bib157","article-title":"MELAS","volume":"2018","author":"El-Hattab","year":"2001"},{"key":"10.1016\/j.survophthal.2019.11.001_bib158","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s10633-010-9241-2","article-title":"Visual evoked potentials findings in non-affected subjects from a large Brazilian pedigree of 11778 Leber's hereditary optic neuropathy","volume":"121","author":"Sacai","year":"2010","journal-title":"Doc Ophthalmol"},{"key":"10.1016\/j.survophthal.2019.11.001_bib159","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s00234-004-1314-z","article-title":"MRI findings in an atypical case of Kearns-Sayre syndrome: A case report","volume":"47","author":"Sacher","year":"2005","journal-title":"Neuroradiology"},{"key":"10.1016\/j.survophthal.2019.11.001_bib160","first-page":"169","article-title":"A\u00a0very large Brazilian pedigree with 11778 Leber's hereditary optic neuropathy","volume":"100","author":"Sadun","year":"2002","journal-title":"Trans Am Ophthalmol Soc"},{"key":"10.1016\/j.survophthal.2019.11.001_bib161","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0002-9394(03)00099-0","article-title":"Extensive investigation of a large Brazilian pedigree of 11778\/haplogroup J Leber hereditary optic neuropathy","volume":"136","author":"Sadun","year":"2003","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.survophthal.2019.11.001_bib162","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1001\/archneurol.2011.2972","article-title":"Effect of EPI-743 on the clinical course of the mitochondrial disease Leber hereditary optic neuropathy","volume":"69","author":"Sadun","year":"2012","journal-title":"Arch Neurol"},{"key":"10.1016\/j.survophthal.2019.11.001_bib163","first-page":"223","article-title":"Leber's hereditary optic neuropathy differentially affects smaller axons in the optic nerve","volume":"98","author":"Sadun","year":"2000","journal-title":"Trans Am Ophthalmol Soc"},{"key":"10.1016\/j.survophthal.2019.11.001_bib164","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.1038\/s41598-018-20838-8","article-title":"OPA1 gene therapy prevents retinal ganglion cell loss in a Dominant Optic Atrophy mouse model","volume":"8","author":"Sarzi","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.survophthal.2019.11.001_bib165","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ophtha.2004.09.033","article-title":"Retinal nerve fiber layer evaluation by optical coherence tomography in unaffected carriers with Leber's hereditary optic neuropathy mutations","volume":"112","author":"Savini","year":"2005","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2019.11.001_bib166","doi-asserted-by":"crossref","first-page":"443","DOI":"10.2165\/00023210-200620060-00002","article-title":"The mitochondrial myopathy encephalopathy, lactic acidosis with stroke-like episodes (MELAS) syndrome: a review of treatment options","volume":"20","author":"Scaglia","year":"2006","journal-title":"CNS Drugs"},{"key":"10.1016\/j.survophthal.2019.11.001_bib167","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/ana.21217","article-title":"Prevalence of mitochondrial DNA disease in adults","volume":"63","author":"Schaefer","year":"2008","journal-title":"Ann Neurol"},{"key":"10.1016\/j.survophthal.2019.11.001_bib168","series-title":"Newcastle Mitochondrial Disease Guidelines Ocular Involvement in Adult Mitochondrial Disease: Screening and Initial Management","author":"Schaefer","year":"2012"},{"key":"10.1016\/j.survophthal.2019.11.001_bib169","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/j.1750-3639.1993.tb00742.x","article-title":"Neuropathy associated with mitochondrial disorders","volume":"3","author":"Schr\u00f6der","year":"1993","journal-title":"Brain Pathol"},{"key":"10.1016\/j.survophthal.2019.11.001_bib170","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.mito.2010.04.001","article-title":"Kearns-Sayre syndrome: cerebral folate deficiency, MRI findings and new cerebrospinal fluid biochemical features","volume":"10","author":"Serrano","year":"2010","journal-title":"Mitochondrion"},{"key":"10.1016\/j.survophthal.2019.11.001_bib171","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.molcel.2015.08.009","article-title":"SPG7 Is an essential and conserved component of the mitochondrial permeability transition pore","volume":"60","author":"Shanmughapriya","year":"2015","journal-title":"Mol Cell"},{"key":"10.1016\/j.survophthal.2019.11.001_bib172","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1086\/342482","article-title":"Identical mitochondrial DNA deletion in a woman with ocular myopathy and in her son with Pearson syndrome","volume":"71","author":"Shanske","year":"2002","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.survophthal.2019.11.001_bib173","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/00002341-198703030-00005","article-title":"Management of ptosis in chronic progressive external ophthalmoplegia","volume":"3","author":"Shorr","year":"1987","journal-title":"Ophthalmic Plast Reconstr Surg"},{"key":"10.1016\/j.survophthal.2019.11.001_bib174","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1001\/archopht.1973.01000050351002","article-title":"Ocular fundus in acute Leber optic neuropathy","volume":"90","author":"Smith","year":"1973","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.survophthal.2019.11.001_bib175","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0002-9394(14)71041-4","article-title":"Strabismus and mitochondrial defects in chronic progressive external ophthalmoplegia","volume":"123","author":"Sorkin","year":"1997","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.survophthal.2019.11.001_bib176","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00005072-199301000-00001","article-title":"Neuropathology of mitochondrial encephalomyopathies due to mitochondrial DNA defects","volume":"52","author":"Sparaco","year":"1993","journal-title":"J\u00a0Neuropathol Exp Neurol"},{"key":"10.1016\/j.survophthal.2019.11.001_bib177","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1743-8454-7-14","article-title":"Choroid plexus failure in the Kearns-Sayre syndrome","volume":"7","author":"Spector","year":"2010","journal-title":"Cerebrospinal Fluid Res"},{"key":"10.1016\/j.survophthal.2019.11.001_bib178","first-page":"10","article-title":"Visual recovery in patients with Leber's hereditary optic neuropathy and the 11778 mutation","volume":"12","author":"Stone","year":"1992","journal-title":"J\u00a0Clin Neuroophthalmol"},{"key":"10.1016\/j.survophthal.2019.11.001_bib179","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jocn.2010.06.014","article-title":"Contribution of muscle biopsy and genetics to the diagnosis of chronic progressive external opthalmoplegia of mitochondrial origin","volume":"18","author":"Sundaram","year":"2011","journal-title":"J\u00a0Clin Neurosci"},{"key":"10.1016\/j.survophthal.2019.11.001_bib180","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S0022-510X(99)00114-8","article-title":"Disconnection of cerebellar Purkinje cells in Kearns-Sayre syndrome","volume":"166","author":"Tanji","year":"1999","journal-title":"J\u00a0Neurol Sci"},{"key":"10.1016\/j.survophthal.2019.11.001_bib181","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0022-510X(00)00354-3","article-title":"Kearns-Sayre syndrome: oncocytic transformation of choroid plexus epithelium","volume":"178","author":"Tanji","year":"2000","journal-title":"J\u00a0Neurol Sci"},{"key":"10.1016\/j.survophthal.2019.11.001_bib182","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1016\/j.addr.2008.05.001","article-title":"The mitochondrial cocktail: rationale for combined nutraceutical therapy in mitochondrial cytopathies","volume":"60","author":"Tarnopolsky","year":"2008","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.survophthal.2019.11.001_bib183","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1002\/ajmg.a.20449","article-title":"Clinical variability in maternally inherited leber hereditary optic neuropathy with the G14459A mutation","volume":"124A","author":"Tarnopolsky","year":"2004","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.survophthal.2019.11.001_bib184","first-page":"1715","article-title":"A\u00a0comprehensive survey of mutations in the OPA1 gene in patients with autosomal dominant optic atrophy","volume":"43","author":"Thiselton","year":"2002","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.survophthal.2019.11.001_bib185","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3109\/09273971003758388","article-title":"The management of strabismus in patients with chronic progressive external ophthalmoplegia","volume":"18","author":"Tinley","year":"2010","journal-title":"Strabismus"},{"key":"10.1016\/j.survophthal.2019.11.001_bib186","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1093\/hmg\/10.13.1369","article-title":"Spectrum, frequency and penetrance of OPA1 mutations in dominant optic atrophy","volume":"10","author":"Toomes","year":"2001","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.survophthal.2019.11.001_bib187","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1136\/jmg.32.4.257","article-title":"A\u00a0new X linked recessive deafness syndrome with blindness, dystonia, fractures, and mental deficiency is linked to Xq22","volume":"32","author":"Tranebjaerg","year":"1995","journal-title":"J\u00a0Med Genet"},{"key":"10.1016\/j.survophthal.2019.11.001_bib188","doi-asserted-by":"crossref","DOI":"10.1242\/dmm.033746","article-title":"Retina-specific loss of Ikbkap\/Elp1 causes mitochondrial dysfunction that leads to selective retinal ganglion cell degeneration in a mouse model of familial dysautonomia","volume":"11","author":"Ueki","year":"2018","journal-title":"Dis Model Mech"},{"key":"10.1016\/j.survophthal.2019.11.001_bib189","first-page":"369","article-title":"Neuroradiologic findings in children with mitochondrial disorders","volume":"19","author":"Valanne","year":"1998","journal-title":"Am J Neuroradiology"},{"key":"10.1016\/j.survophthal.2019.11.001_bib190","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1167\/iovs.06-0331","article-title":"Male prevalence of acquired color vision defects in asymptomatic carriers of Leber's hereditary optic neuropathy","volume":"48","author":"Ventura","year":"2007","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.survophthal.2019.11.001_bib191","first-page":"125","article-title":"Verhandlungen \u00e4rztlicher Gesellschaften","volume":"5","author":"Von Graefe","year":"1868","journal-title":"Berl Klin Wochenschr"},{"key":"10.1016\/j.survophthal.2019.11.001_bib192","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1001\/archopht.116.3.351","article-title":"Clinical features in affected individuals from 21 pedigrees with dominant optic atrophy","volume":"116","author":"Votruba","year":"1998","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.survophthal.2019.11.001_bib193","first-page":"703","article-title":"Genetic and biochemical impairment of mitochondrial complex I activity in a family with Leber hereditary optic neuropathy and hereditary spastic dystonia","volume":"58","author":"De Vries","year":"1996","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.survophthal.2019.11.001_bib194","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1126\/science.3201231","article-title":"Mitochondrial DNA mutation associated with Leber's hereditary optic neuropathy","volume":"242","author":"Wallace","year":"1988","journal-title":"Science"},{"key":"10.1016\/j.survophthal.2019.11.001_bib195","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/S0161-6420(97)30250-4","article-title":"Surgical management of strabismus associated with chronic progressive external ophthalmoplegia","volume":"104","author":"Wallace","year":"1997","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2019.11.001_bib196","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1056\/NEJMoa064436","article-title":"A\u00a0lethal defect of mitochondrial and peroxisomal fission","volume":"356","author":"Waterham","year":"2007","journal-title":"N\u00a0Engl J Med"},{"issue":"Suppl 1","key":"10.1016\/j.survophthal.2019.11.001_bib197","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1016\/S0039-6257(03)00004-3","article-title":"Role of alpha-2 agonists in neuroprotection","volume":"48","author":"Wheeler","year":"2003","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.survophthal.2019.11.001_bib198","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1006\/bbrc.1997.6660","article-title":"Mutation analysis of the ND6 gene in patients with Lebers hereditary optic neuropathy","volume":"234","author":"Wissinger","year":"1997","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.survophthal.2019.11.001_bib199","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/S0161-6420(02)01009-6","article-title":"Management of myogenic ptosis","volume":"109","author":"Wong","year":"2002","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2019.11.001_bib200","first-page":"2275","article-title":"Costeff syndrome: clinical features and natural history","volume":"261","author":"Yahalom","year":"2014","journal-title":"J\u00a0Neurol"},{"key":"10.1016\/j.survophthal.2019.11.001_bib201","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1007\/s10038-008-0289-8","article-title":"Genotype and phenotype analyses in 136 patients with single large-scale mitochondrial DNA deletions","volume":"53","author":"Yamashita","year":"2008","journal-title":"J\u00a0Hum Genet"},{"key":"10.1016\/j.survophthal.2019.11.001_bib202","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s13238-017-0499-y","article-title":"Targeted elimination of mutant mitochondrial DNA in MELAS-iPSCs by mitoTALENs","volume":"9","author":"Yang","year":"2018","journal-title":"Protein Cell"},{"key":"10.1016\/j.survophthal.2019.11.001_bib203","doi-asserted-by":"crossref","first-page":"e6","DOI":"10.1371\/journal.pgen.0040006","article-title":"The molecular mechanisms of OPA1-mediated optic atrophy in Drosophila model and prospects for antioxidant treatment","volume":"4","author":"Yarosh","year":"2008","journal-title":"Plos Genet"},{"key":"10.1016\/j.survophthal.2019.11.001_bib204","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.bbagen.2011.03.015","article-title":"MELAS: a nationwide prospective cohort study of 96 patients in Japan","volume":"1820","author":"Yatsuga S","year":"2012","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.survophthal.2019.11.001_bib205","doi-asserted-by":"crossref","first-page":"4929","DOI":"10.1093\/hmg\/ddx373","article-title":"Rescue of cell death and inflammation of a mouse model of complex 1-mediated vision loss by repurposed drug molecules","volume":"26","author":"Yu","year":"2017","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.survophthal.2019.11.001_bib206","doi-asserted-by":"crossref","DOI":"10.1016\/j.ophtha.2013.04.022","article-title":"Dominant optic atrophy: novel OPA1 mutations and revised prevalence estimates","volume":"120","author":"Yu-Wai-Man","year":"2013","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2019.11.001_bib207","first-page":"5109","article-title":"A\u00a0national epidemiological study of chronic progressive external ophthalmoplegia in the United Kingdom - molecular genetic features and neurological burden","volume":"55","author":"Yu-Wai-Man","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.survophthal.2019.11.001_bib208","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1016\/j.ophtha.2009.12.038","article-title":"The prevalence and natural history of dominant optic atrophy due to OPA1 mutations","volume":"117","author":"Yu-Wai-Man","year":"2010","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2019.11.001_bib209","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1136\/jmg.2007.054270","article-title":"Inherited mitochondrial optic neuropathies","volume":"46","author":"Yu-Wai-Man","year":"2009","journal-title":"J\u00a0Med Genet"},{"key":"10.1016\/j.survophthal.2019.11.001_bib210","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.nmd.2004.10.002","article-title":"Extraocular muscles have fundamentally distinct properties that make them selectively vulnerable to certain disorders","volume":"15","author":"Yu Wai Man","year":"2005","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.survophthal.2019.11.001_bib211","first-page":"291","article-title":"Mitochondrial cytochrome b gene deletion in Kearns-Sayre syndrome associated with a subclinical type of peripheral neuropathy","volume":"17","author":"Zanssen","year":"1998","journal-title":"Clin Neuropathol"},{"key":"10.1016\/j.survophthal.2019.11.001_bib212","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1212\/WNL.38.8.1339","article-title":"Deletions of mitochondrial DNA in Kearns-Sayre syndrome","volume":"38","author":"Zeviani","year":"1988","journal-title":"Neurology"},{"key":"10.1016\/j.survophthal.2019.11.001_bib213","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.4103\/0366-6999.183417","article-title":"Clinical and brain magnetic resonance imaging features in a cohort of chinese patients with Kearns-Sayre syndrome","volume":"129","author":"Zhang","year":"2016","journal-title":"Chin Med J"},{"key":"10.1016\/j.survophthal.2019.11.001_bib214","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jns.2017.12.033","article-title":"Survival analysis of a cohort of Chinese patients with mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes (MELAS) based on clinical features","volume":"385","author":"Zhang","year":"2018","journal-title":"J\u00a0Neurol Sci"},{"key":"10.1016\/j.survophthal.2019.11.001_bib215","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3109\/13816810.2015.1130153","article-title":"Ophthalmological findings in 74 patients with mitochondrial disease","volume":"38","author":"Zhu","year":"2017","journal-title":"Ophthalmic Genet"},{"key":"10.1016\/j.survophthal.2019.11.001_bib216","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1007\/s00417-015-2979-1","article-title":"Multifocal VEP provide electrophysiological evidence of predominant dysfunction of the optic nerve fibers derived from the central retina in Leber's hereditary optic neuropathy","volume":"253","author":"Ziccardi","year":"2015","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.survophthal.2019.11.001_bib217","doi-asserted-by":"crossref","first-page":"6893","DOI":"10.1167\/iovs.13-12894","article-title":"Retinal function and neural conduction along the visual pathways in affected and unaffected carriers with Leber's hereditary optic neuropathy","volume":"54","author":"Ziccardi","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"}],"container-title":["Survey of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039625719302887?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039625719302887?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T11:49:46Z","timestamp":1758541786000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039625719302887"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":217,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["S0039625719302887"],"URL":"https:\/\/doi.org\/10.1016\/j.survophthal.2019.11.001","relation":{},"ISSN":["0039-6257"],"issn-type":[{"value":"0039-6257","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mitochondrial disorders and the eye","name":"articletitle","label":"Article Title"},{"value":"Survey of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.survophthal.2019.11.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}